Sandrina Lambrechts

4.9k total citations
36 papers, 777 citations indexed

About

Sandrina Lambrechts is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Sandrina Lambrechts has authored 36 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Reproductive Medicine, 13 papers in Obstetrics and Gynecology and 10 papers in Oncology. Recurrent topics in Sandrina Lambrechts's work include Ovarian cancer diagnosis and treatment (29 papers), Endometrial and Cervical Cancer Treatments (12 papers) and Cancer Genomics and Diagnostics (6 papers). Sandrina Lambrechts is often cited by papers focused on Ovarian cancer diagnosis and treatment (29 papers), Endometrial and Cervical Cancer Treatments (12 papers) and Cancer Genomics and Diagnostics (6 papers). Sandrina Lambrechts collaborates with scholars based in Belgium, Netherlands and Germany. Sandrina Lambrechts's co-authors include Ignace Vergote, Dan Cacsire Castillo‐Tong, Elena Ioana Braicu, Jalid Sehouli, Robert Zeillinger, Sven� Mahner, Roy F.P.M. Kruitwagen, Toon Van Gorp, B.F.M. Slangen and Els Van Nieuwenhuysen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Molecular Cancer.

In The Last Decade

Sandrina Lambrechts

34 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandrina Lambrechts Belgium	18	402	280	236	203	184	36	777
Robert L. Hollis United Kingdom	15	431 1.1×	255 0.9×	256 1.1×	138 0.7×	158 0.9×	32	695
Satoshi Tsunetoh Japan	15	235 0.6×	280 1.0×	243 1.0×	159 0.8×	188 1.0×	32	715
Satoe Fujiwara Japan	14	210 0.5×	279 1.0×	227 1.0×	169 0.8×	168 0.9×	38	677
Alexandre André Balieiro Anastácio da Costa Brazil	18	276 0.7×	343 1.2×	301 1.3×	109 0.5×	246 1.3×	64	832
Deanna Teoh United States	12	400 1.0×	253 0.9×	173 0.7×	87 0.4×	193 1.0×	20	708
Ingirídur Skírnisdóttir Sweden	16	499 1.2×	176 0.6×	234 1.0×	107 0.5×	204 1.1×	26	682
Atsuko Katagiri Japan	17	351 0.9×	621 2.2×	205 0.9×	231 1.1×	135 0.7×	37	956
Munmun Rahman Japan	15	269 0.7×	537 1.9×	178 0.8×	207 1.0×	108 0.6×	34	806
Alejandro Rojo‐Sebastián Spain	14	142 0.4×	375 1.3×	122 0.5×	114 0.6×	200 1.1×	18	686
Adriaan Vanderstichele Belgium	14	266 0.7×	288 1.0×	300 1.3×	327 1.6×	43 0.2×	29	752

Countries citing papers authored by Sandrina Lambrechts

Since Specialization

Citations

This map shows the geographic impact of Sandrina Lambrechts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrina Lambrechts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrina Lambrechts more than expected).

Fields of papers citing papers by Sandrina Lambrechts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrina Lambrechts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrina Lambrechts. The network helps show where Sandrina Lambrechts may publish in the future.

Co-authorship network of co-authors of Sandrina Lambrechts

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrina Lambrechts. A scholar is included among the top collaborators of Sandrina Lambrechts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrina Lambrechts. Sandrina Lambrechts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bizzarri, Nicolò, Víctor Lago, Núria Agustí, et al.. (2025). Incidence And Impact Of Low Volume Lymph Node Metastasis In Apparent Early-Stage Ovarian Cancer – MICR-OVARY Study.. International Journal of Gynecological Cancer. 35(2). 100347–100347.

Lok, Christianne, Joanne A. de Hullu, H.P.M. Smedts, et al.. (2023). Functional estrogen receptor signal transduction pathway activity and antihormonal therapy response in low‐grade ovarian carcinoma. Cancer. 129(9). 1361–1371. 4 indexed citations

Thijs, Anna M.J., Hans M. Westgeest, H.P.M. Smedts, et al.. (2023). Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol. Heliyon. 10(1). e23170–e23170. 2 indexed citations

Westgeest, Hans M., Ingrid Boere, P.B. Ottevanger, et al.. (2023). The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis. Gynecologic Oncology. 171. 83–94. 44 indexed citations

Kruitwagen, Roy F.P.M., Johan Bulten, Dorry Boll, et al.. (2022). Sentinel Lymph Node Mapping in Presumed Low- and Intermediate-Risk Endometrial Cancer Management (SLIM): A Multicenter, Prospective Cohort Study in The Netherlands. Cancers. 15(1). 271–271. 5 indexed citations

Dell’Orto, Federica, et al.. (2019). Feasibility of sentinel lymph node mapping of the ovary: a systematic review. International Journal of Gynecological Cancer. 29(7). 1209–1215. 25 indexed citations

Meshcheryakova, Anastasia, Martin Svoboda, Markus Jaritz, et al.. (2019). Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer. Computational and Structural Biotechnology Journal. 17. 537–560. 21 indexed citations

Lambrechts, Sandrina, et al.. (2018). Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary Surgery. International Journal of Gynecological Cancer. 28(4). 721–728. 7 indexed citations

Leunen, Karin, et al.. (2016). Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer. International Journal of Gynecological Cancer. 26(8). 1521–1524. 11 indexed citations

10.

Svoboda, Martin, Anastasia Meshcheryakova, Georg Heinze, et al.. (2016). AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer. BMC Genomics. 17(1). 643–643. 12 indexed citations

11.

Lambrechts, Sandrina, Diether Lambrechts, Evelyn Despierre, et al.. (2015). Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC Pharmacology and Toxicology. 16(1). 2–2. 36 indexed citations

12.

Aust, Stefanie, Katharina Auer, Anna Bachmayr-Heyda, et al.. (2014). Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium. Molecular Cancer. 13(1). 67–67. 14 indexed citations

13.

Braicu, Elena Ioana, Rolf Richter, Dan Cacsire Castillo‐Tong, et al.. (2014). HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium. OncoTargets and Therapy. 7. 1563–1563. 17 indexed citations

14.

Despierre, Evelyn, Betül T. Yesilyurt, Sandrina Lambrechts, et al.. (2014). Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 24(3). 468–477. 25 indexed citations

15.

Despierre, Evelyn, Matthieu Moisse, Betül T. Yesilyurt, et al.. (2014). Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer. Gynecologic Oncology. 135(3). 415–422. 32 indexed citations

16.

Bachmayr-Heyda, Anna, Stefanie Aust, Georg Heinze, et al.. (2013). Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium. BMC Cancer. 13(1). 422–422. 54 indexed citations

17.

Trillsch, Fabian, Linn Woelber, Christine Eulenburg, et al.. (2013). Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium. Journal of Ovarian Research. 6(1). 42–42. 42 indexed citations

18.

Pils, Dietmar, Anna Bachmayr-Heyda, Katharina Auer, et al.. (2013). Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – A study of the OVCAD consortium. European Journal of Cancer. 50(1). 99–110. 50 indexed citations

19.

Nieuwenhuysen, Els Van, Sandrina Lambrechts, Diether Lambrechts, et al.. (2013). Genetic changes in nonepithelial ovarian cancer. Expert Review of Anticancer Therapy. 13(7). 871–882. 17 indexed citations

20.

Monk, Bradley J., et al.. (2013). Incidence and management of edema associated with trebananib (AMG 386). Gynecologic Oncology. 130(3). 636–641. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact